Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus A Horwitz

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Plos One|November 15, 2018
Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibilityBai-Yu Lee, Daniel L Clemens, Aleidy Silva, et al.
Nature Methods|April 8, 2015
Massively parallel delivery of large cargo into mammalian cells with light pulsesYi-Chien Wu, Ting-Hsiang Wu, Daniel L Clemens, et al.
Nature Communications|January 25, 2017
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment timeBai-Yu Lee, Daniel L Clemens, Aleidy Silva, et al.
Blood|May 4, 2017
Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound ironDeborah Stefanova, Antoan Raychev, Joao Arezes, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticlesDaniel L Clemens, Bai-Yu Lee, Min Xue, et al.
Plos One|May 11, 2019
Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugsDaniel L Clemens, Bai-Yu Lee, Aleidy Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2002
Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injuryFarin Amersi, Sally K Nelson, Xiu Da Shen, et al.
The Journal of Infectious Diseases|September 24, 2008
A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteersDaniel F Hoft, Azra Blazevic, Getahun Abate, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2002
Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitizationMichael J Whitekus, Ning Li, Min Zhang, et al.
ACS Infectious Diseases|November 28, 2018
Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse ModelDaniel L Clemens, Bai-Yu Lee, Sheba Plamthottam, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Plos One|November 15, 2018
Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibilityBai-Yu Lee, Daniel L Clemens, Aleidy Silva, et al.
Nature Methods|April 8, 2015
Massively parallel delivery of large cargo into mammalian cells with light pulsesYi-Chien Wu, Ting-Hsiang Wu, Daniel L Clemens, et al.
Nature Communications|January 25, 2017
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment timeBai-Yu Lee, Daniel L Clemens, Aleidy Silva, et al.
Blood|May 4, 2017
Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound ironDeborah Stefanova, Antoan Raychev, Joao Arezes, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticlesDaniel L Clemens, Bai-Yu Lee, Min Xue, et al.
Plos One|May 11, 2019
Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugsDaniel L Clemens, Bai-Yu Lee, Aleidy Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2002
Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injuryFarin Amersi, Sally K Nelson, Xiu Da Shen, et al.
The Journal of Infectious Diseases|September 24, 2008
A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteersDaniel F Hoft, Azra Blazevic, Getahun Abate, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2002
Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitizationMichael J Whitekus, Ning Li, Min Zhang, et al.
ACS Infectious Diseases|November 28, 2018
Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse ModelDaniel L Clemens, Bai-Yu Lee, Sheba Plamthottam, et al.
Pageof 8